Drugs / ShefaBone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04433117 | Jun 2020 → Feb 2023 | bone resorption disease, tooth disorder | Mohanad Al-Sabbagh | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ShefaBone | “One type of SBS includes porous granules of bioactive and resorbable silica-calcium phosphate nanocomposite (ShefaBone).” NCT04433117 ↗ |
| Modality | Other / unclassified | “Shefabone synthetic bone substitute.” NCT04433117 ↗ |